'Real-world' UK data shows 70% decline in COVID infections after first Pfizer shot
- S&P, Nasdaq futures rise as JPMorgan, Goldman set to kick off earnings season
- JPMorgan (JPM) Tops Q1 EPS by $1.40, Revenues Beat
- Coinbase (COIN) direct listing IPO reference price set at $250
- Oil maintains upward momentum despite fresh coronavirus fears
- Dollar nurses losses as 'mean reversion' trade widens
People walk past a mural on the windows of a closed pizza restaurant amid the outbreak of the coronavirus disease (COVID-19) in Manchester, Britain, February 22, 2021. REUTERS/Phil Noble
Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
LONDON (Reuters) - England's coronavirus vaccine campaign is significantly reducing cases of COVID-19, with a drop of around 70% in infections among healthcare workers who have had a first dose of the Pfizer-BioNTech shot, British health officials said on Monday.
Data analysed by Public Health England (PHE) showed the Pfizer provided high levels of protection against infection and symptomatic disease from a single dose, and that hospitalisation and death from COVID-19 will be reduced by more 75% in elderly people who have had a first dose.
"Overall, we're seeing a really strong effect to reducing any infection, asymptomatic and symptomatic," PHE's strategic response director Susan Hopkins told a media briefing.
PHE's head of immunisation Mary Ramsay described the data as "strong evidence that the Pfizer-BioNTech vaccine is stopping people from getting infected, while also protecting cases against hospitalisation and death".
"We should be very encouraged by these initial findings," she said.
PHE's findings came from two separate analyses - one is an ongoing study in healthcare workers, and the second is an assessment of testing data in people aged 80 and over.
Evidence from the elderly group showed that one dose of the Pfizer shot is 57% effective against symptomatic COVID-19 disease, PHE said, and early data suggest the second dose improves protection to more than 85%.
"Hospitalisation and deaths rates are falling in all age groups, but the oldest age groups are seeing the fastest decline since the peak in mid-January," a PHE statement said.
The vaccine also provides protection against the so-called British variant of the SARS-CoV-2 coronavirus, it added.
The PHE data come as preliminary study findings from Scotland on Monday also showed the vaccination drive there is working, markedly reducing the risk of hospitalisation for COVID-19.
Scottish researchers said those findings suggested that both the Pfizer and the Oxford-AstraZeneca COVID-19 vaccines are highly effective in preventing severe infections.
(Reporting by Kate Kelland and Alistair Smout, editing by Guy Faulconbridge)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- U.S. Not Seeing Clot Events with Other Vaccines, Official Says
- UK asks for more time to respond to EU Brexit legal action: RTE TV
- Kindergartens to reopen, but Poland keeps most coronavirus curbs
Create E-mail Alert Related CategoriesFDA, General News, Reuters
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!